Saturday 17 October 2026 Export MASS’s income statement to Excel — free account

908 Devices Inc.

In the quarter to June 2026, revenue grew 23.3%, EPS grew 13.5% and free cash flow grew 151.0%, each against the same quarter a year earlier.

11.33 0.56 −4.71%

Follow MASS

Alert me

Market cap: $491.5M
P/E: 0.0×
Fwd P/E: −13.3×
Dividend yield: —
F-score: 5/9
Altman Z: 1.10
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 9.96

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	2	1	3	8	8	2	7	4	2

Insider Ownership 13.35%

Capital & Financial Ratios $m

Market Cap 491.46

Revenue 60.84

Net Income (34.66)

Free Cash Flow 0.62

Net Debt (101.53)

Current Ratio 2.67

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (13.30)

P/S ratio 7.03

P/B ratio 3.37

Past 5Y EPS Growth —

This Y EPS Growth (494.89%)

Next Y EPS Growth 49.65%

Next Y revenue growth 22.98%

Next 5Y EPS Growth (15.07%)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 65.82%

10-year low 10-year high

P/B against its own 10 years 84.33%

10-year low 10-year high

EV/Sales against its own 10 years 69.92%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	146	69	113	102
Receivables	9	9	11	12
Inventory	15	11	13	14
Other	—	—	—	—
	174	103	145	132

	2023	2024	2025	Q'26
Payables	1	1	2	3
ST’ Debt	—	—	—	—
Other	—	—	16	30
	23	25	34	49

Compound Annual Growth %

	10y	5y	3y
Sales	—	15.88%	6.25%
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.66%	(8.99%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	13	16	—	—	—
’25	12	13	14	17	56
’24	7	11	15	14	48
’23	9	12	14	14	50
’22	8	11	16	12	47
’21	6	8	13	16	42
’20	4	11	6	6	27

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	1	3	—	—	—
’25	(15)	(6)	(4)	1	(24)
’24	(9)	(13)	(6)	(2)	(30)
’23	(11)	(8)	(5)	(2)	(25)
’22	0	(10)	(5)	(5)	(21)
’21	(10)	(7)	(3)	(9)	(29)
’20	(3)	(3)	8	2	4

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	1	3	—	—	—
’25	(15)	(6)	(5)	1	(25)
’24	(10)	(12)	(6)	(2)	(31)
’23	(12)	(8)	(5)	(2)	(27)
’22	(1)	(10)	(6)	(6)	(23)
’21	(10)	(8)	(3)	(9)	(30)
’20	(3)	(3)	8	2	4

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.32)	(0.32)	—	—	—
’25	1.23	(0.37)	(0.41)	0.10	0.54
’24	(0.33)	(0.37)	(0.84)	(0.56)	(2.12)
’23	(0.39)	(0.29)	(0.22)	(0.23)	(1.13)
’22	(0.30)	(0.26)	(0.20)	(0.31)	(1.07)
’21	(0.22)	(0.27)	(0.19)	(0.12)	(0.79)
’20	(0.59)	0.37	(0.34)	(1.48)	(2.35)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	43.25	22.21	6.87	4.85	1.81	1.92	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	74.00	79.60	26.63	12.51	11.16	9.34
People
People	Employees	—	—	—	—	101	177	227	230	246	172
	Revenue/emp, $m	—	—	0.00	0.00	0.27	0.24	0.21	0.22	0.19	0.33
Income, $m
Income, $m	Revenue	—	—	22	18	27	42	47	50	48	56
	Gross margin, %	—	—	56.19	45.31	55.49	55.05	55.54	50.41	51.31	50.58
	EBT	—	—	(8)	(13)	(13)	(22)	(34)	(37)	(53)	(33)
	EBT margin, %	—	—	(34.17)	(74.41)	(47.66)	(52.53)	(71.64)	(72.89)	(111.30)	(59.33)
	Net income	—	0	(8)	(13)	(13)	(22)	(34)	(36)	(72)	19
	Depreciation	—	—	1	1	1	1	2	2	45	4
Per share, $
Per share, $	Revenue	—	—	0.84	3.60	4.90	1.51	1.49	1.56	1.40	1.57
	Earnings	—	—	(0.29)	(2.68)	(2.35)	(0.79)	(1.07)	(1.13)	(2.12)	0.54
	Cash flow	—	—	(0.34)	(2.21)	0.75	(1.04)	(0.66)	(0.78)	(0.89)	(0.66)
	Capex	—	—	0.00	(0.08)	0.00	(0.03)	(0.06)	(0.06)	(0.02)	(0.03)
	Free cash flow	—	—	(0.34)	(2.28)	0.75	(1.07)	(0.73)	(0.84)	(0.91)	(0.69)
	Book value	—	—	0.11	(12.66)	25.35	7.68	6.05	5.13	3.36	4.00
	Shares, m	—	—	26	5	5	28	31	32	34	36
Valuation, ×
Valuation, ×	P/E	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.38
	P/S	—	—	8.30	8.30	14.70	17.14	4.93	6.37	1.57	3.35
	P/B	—	—	0.00	0.00	2.84	3.37	1.21	1.93	0.65	1.31
	EV/Sales	—	—	8.38	8.38	9.33	12.20	1.24	3.78	0.45	1.62
	EV/FCF	—	—	(25.75)	(25.75)	60.88	(17.26)	(2.53)	(7.00)	(0.70)	(3.69)
Cash, $m
Cash, $m	Operating cash flow	—	—	(9)	(11)	4	(29)	(21)	(25)	(30)	(24)
	Capex	—	—	(1)	0	0	(1)	(2)	(2)	(1)	(1)
	Free cash flow	—	—	(9)	(11)	4	(30)	(23)	(27)	(31)	(25)
Balance, $m
Balance, $m	Working capital	—	—	12	23	160	238	196	151	78	110
	Total debt	—	—	18	16	15	15	15	—	—	—
	Net debt	—	—	11	(2)	(144)	(209)	(173)	(146)	(69)	(113)
	Shareholders’ equity	—	—	3	(63)	139	215	191	165	115	144
Returns, %
Returns, %	ROA	—	—	(54.87)	(41.22)	(11.93)	(10.08)	(13.33)	(16.34)	(39.84)	11.15
	ROIC	—	—	0.00	0.00	0.00	(249.38)	(128.74)	(134.91)	(78.54)	(80.18)
	ROE	—	—	13.43	23.79	(34.03)	(12.54)	(16.57)	(20.44)	(51.56)	15.09

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
TCMD Tactile Systems Technology, Inc.	$527.6M	20.5×	22.7×	+8.61% (above 0%: growing)	+142.86% (above 0%: growing)	−86.53% (below 0%: shrinking)	76.25%	7.97%	Compare
SSII SS Innovations International, Inc.	$517.2M	— (loss-making)	— (loss-making)	+39.39% (above 0%: growing)	n/m	−16.62% (below 0%: shrinking)	50.94%	(16.29%)	Compare
DCTH Delcath Systems, Inc.	$513.9M	1,408×	— (loss-making)	+20.60% (above 0%: growing)	−12.50% (below 0%: shrinking)	−24.45% (below 0%: shrinking)	89.75%	8.22%	Compare
MASS 908 Devices Inc.	$491.5M	— (loss-making)	— (loss-making)	+23.31% (above 0%: growing)	n/m	+150.95% (above 0%: growing)	51.90%	(79.69%)
SGHT Sight Sciences, Inc.	$484.8M	— (loss-making)	— (loss-making)	+19.55% (above 0%: growing)	n/m	+26.71% (above 0%: growing)	91.39%	(16.62%)	Compare
BWAY Brainsway Ltd. Sponsored ADR	$475.8M	24.8×	— (loss-making)	+35.43% (above 0%: growing)	+40.00% (above 0%: growing)	−51.68% (below 0%: shrinking)	74.62%	13.98%	Compare
CERS Cerus Corporation	$455.5M	— (loss-making)	— (loss-making)	+5.28% (above 0%: growing)	n/m	−20.90% (below 0%: shrinking)	55.91%	(2.94%)	Compare
NPCE NeuroPace, Inc.	$438.7M	— (loss-making)	— (loss-making)	+17.05% (above 0%: growing)	n/m	−78.70% (below 0%: shrinking)	82.83%	(22.53%)	Compare
SENS Senseonics Holdings, Inc.	$435.2M	— (loss-making)	— (loss-making)	+117.82% (above 0%: growing)	n/m	−223.24% (below 0%: shrinking)	59.10%	(248.48%)	Compare
Median of peers	$480.3M	24.8×	—	+20.07%	+40.00%	−38.07%	75.44%	(9.61%)

All 149 Medical Devices stocks →

908 Devices Inc. (MASS) key facts

908 Devices Inc. (MASS) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
Net income was $19.5 million, or $0.54 per share (basic), a net margin of 34.7%.
As of October 16, 2026, MASS traded at $11.33, a market capitalization of $491.5 million.
Return on equity was 15.1% and debt-to-equity 0.00.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 1.10 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.